Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 5, 2024Business Wire • 07/18/24
Arcturus Therapeutics Provides Updates for Ornithine Transcarbamylase (OTC) Deficiency and Cystic Fibrosis (CF) ProgramsBusiness Wire • 07/01/24
Arcturus Therapeutics Presents New Clinical Data at 47th Annual European Cystic Fibrosis ConferenceBusiness Wire • 06/07/24
Arcturus Therapeutics Announces Positive Development for Cystic Fibrosis ProgramBusiness Wire • 05/28/24
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 VaccineBusiness Wire • 05/20/24
Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline ProgressBusiness Wire • 05/08/24
Analysts Estimate Arcturus Therapeutics (ARCT) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 05/01/24
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024Business Wire • 04/25/24
Arcturus Therapeutics' ARCT-032: Might Be The Next Breakthrough In Cystic FibrosisSeeking Alpha • 04/23/24
Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/07/24
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline ProgressBusiness Wire • 03/07/24
Arcturus Therapeutics to Present at the Barclays 26th Annual Global Healthcare ConferenceBusiness Wire • 02/26/24
Arcturus Therapeutics Receives Orphan Medicinal Product Designation from the European Commission (EC), for ARCT-032, for the Treatment of Cystic FibrosisBusiness Wire • 02/22/24
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for February 2024InvestorPlace • 02/21/24
Arcturus Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 7, 2024Business Wire • 02/20/24
New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine BoosterPRNewsWire • 02/05/24
Why Arcturus Therapeutics Has A Promising Future With Innovative CF And COVID TreatmentsSeeking Alpha • 02/02/24